Can Cilacar (Cilnidipine) Be Given Twice Daily?
Cilnidipine is designed and proven effective as a once-daily antihypertensive medication and should not be routinely administered twice daily. The drug's pharmacological properties and clinical evidence consistently demonstrate sustained 24-hour blood pressure control with single daily dosing 1, 2, 3, 4.
Evidence Supporting Once-Daily Dosing
Pharmacological Rationale
Cilnidipine's dual L-type and N-type calcium channel blocking action provides prolonged antihypertensive effects that persist throughout a 24-hour period. Multiple studies have confirmed:
- 24-hour blood pressure control: Once-daily cilnidipine (5-20 mg) significantly reduces both daytime and nighttime blood pressure without requiring split dosing 4
- Sustained efficacy: The drug maintains therapeutic blood pressure reductions across the entire dosing interval, including the critical early morning hours when cardiovascular events peak 1, 5
- No reflex tachycardia: Unlike other calcium channel blockers, cilnidipine does not increase heart rate or sympathetic nervous activity, eliminating a common reason for dose splitting 2, 3
Clinical Trial Evidence
The research consistently demonstrates once-daily effectiveness:
- A randomized crossover study showed cilnidipine administered once daily (morning or bedtime) reduced 24-hour systolic blood pressure effectively regardless of timing, with partial inhibition of morning sympathetic activation 1
- Ambulatory blood pressure monitoring studies confirmed that once-daily dosing provides adequate blood pressure reduction throughout the day and night without excessive nocturnal drops 4
- Comparative studies against twice-daily nifedipine retard showed cilnidipine once daily had less influence on heart rate and autonomic function while maintaining equivalent blood pressure control 3
When Bedtime Dosing May Be Preferred
For patients with uncontrolled morning hypertension despite other treatments, adding cilnidipine 10 mg at bedtime (not splitting the dose) is the evidence-based approach 5. This strategy:
- Significantly reduces morning blood pressure surge (150.2/87.8 to 132.7/77.5 mmHg)
- Decreases the morning-evening blood pressure difference
- Reduces microalbuminuria
- Does not cause morning heart rate changes
Critical Pitfalls to Avoid
Do not confuse cilnidipine with the topical product "Cilacar" mentioned in the FDA drug labels 6 - those references describe a completely different topical preparation for skin irritations applied 2-3 times daily, not the oral antihypertensive cilnidipine.
Do not extrapolate twice-daily dosing practices from other antihypertensives - while some ACE inhibitors like lisinopril may show benefit from twice-daily administration 7, cilnidipine's unique dual calcium channel blockade and pharmacokinetic profile make this unnecessary.
Practical Dosing Algorithm
- Start with once-daily dosing: 5-10 mg cilnidipine once daily (morning or evening based on patient preference for adherence)
- If morning hypertension persists: Switch timing to bedtime administration (still once daily)
- If blood pressure remains uncontrolled: Increase dose up to 20 mg once daily before considering combination therapy
- If still inadequate: Add a second antihypertensive class per guidelines 8 rather than splitting cilnidipine doses
The evidence does not support twice-daily cilnidipine dosing, and doing so would deviate from established efficacy and safety data without proven benefit.